Effect of Glycopyrronium on QT interval in healthy subjects: A randomized, 3-period cross-over, placebo- and positive-controlled study
Phase of Trial: Phase II
Latest Information Update: 22 Oct 2013
Price : $35 *
At a glance
- Drugs Glycopyrrolate (Primary) ; Moxifloxacin
- Indications Chronic obstructive pulmonary disease
- Focus Pharmacodynamics
- 22 Oct 2013 New trial record
- 13 Sep 2013 Primary endpoint 'QT-interval' has been met.
- 11 Sep 2013 Results presented at the 23rd Annual Congress of the European Respiratory Society.